Evidence map›Paper›PMID 39356942›Full record

ArticleEinstein (Sao Paulo, Brazil)2024

Acute kidney injury in coronavirus disease: a comparative study of the two waves in Brazil.

Luis Eduardo Magalhães, Ana Júlia Favarin, Pedro Andriolo Cardoso, Bruna Kaori Yuasa, Welder Zamoner, André Luís Balbi, Daniela Ponce

Abstract readComparative Study
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Eduardo MagalhãesFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0003-4211-6952
Ana Júlia FavarinFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0001-9222-8851
Pedro Andriolo CardosoFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0002-3191-3035
Bruna Kaori YuasaFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0002-4185-2854
Welder ZamonerFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0003-2756-6621
André Luís BalbiFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0001-8366-5064
Daniela PonceFaculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.ORCID http://orcid.org/0000-0002-6178-6938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMagalhães et al. demonstrated that the incidence of acute kidney injury was high in hospitalized patients with COVID-19 and that the second wave was associated with greater severity; however, the mortality rates were similar between the two periods. This may reflect both the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic to provide greater support to their patients.

background◼ Renal involvement was frequent in patients with COVID-19 and related to worse outcomes.

background◼ Diuretic use, mechanical ventilation, proteinuria, hematuria, age, and creatine phosphokinase and D-dimer levels were risk factors for acute kidney injury.

background◼ Acute kidney injury, mechanical ventilation, elevated SOFA Score, and elevated ATN-ISS were associated with mortality.

background◼ The second wave was associated with greater severity; however, the mortality rates were similar between the two periods.

background◼ This may reflect the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic.

objectiveThis study aimed to evaluate the incidence of acute kidney injury in hospitalized Brazilian patients with COVID-19 and identify the risk factors associated with its development and prognosis during the two waves of the disease.

methodsWe performed a prospective cohort study of hospitalized patients with COVID-19 at a public university hospital in São Paulo from March 2020 to May 2021.

resultsOf 887 patients hospitalized with COVID-19, 54.6% were admitted to the intensive care unit. The incidence of acute kidney injury was 48.1%, and the overall mortality rate was 38.9%. Acute kidney replacement therapy was indicated for 58.8% of the patients. The factors associated with acute kidney injury were diuretic use (odds ratio [OR] 2.2, 95%CI= 1.2-4.1, p=0.01), mechanical ventilation (OR= 12.9, 95%CI= 4.3-38.2, p<0.0001), hematuria(OR= 2.02, 95%CI= 1.1-3.5, p<0.0001), chronic kidney disease (OR= 2.6, 95%CI= 1.2-5.5, p=0.009), age (OR= 1.03, 95%CI= 1.01-1.07, p=0.02), and elevated creatine phosphokinase (OR= 1.02, 95%CI= 1.01-1.07, p=0.02) and D-dimer levels (OR= 1.01, 95%CI= 1.01-1.09, p<0.0001). Mortality was higher among those with acute kidney injury (OR= 1.12, 95%CI= 1.02-2.05, p=0.01), elevated Sequential Organ Failure Assessment Scores (OR= 1.35, 95%CI= 1.1-1.6, p=0.007), elevated Acute Tubular Necrosis-Injury Severity Score (ATN-ISS; (OR= 96.4, 95%CI= 4.8-203.1, p<0.0001), and who received mechanical ventilation (OR= 12.9, 95%CI= 4.3-38.2, p<0.0001). During the second wave, the number of cases requiring mechanical ventilation (OR= 1.57, 95%CI= 1.01-2.3, p=0.026), with proteinuria (OR= 1.44, 95%CI= 1.01-2.1, p=0.04), and with higher ATN-ISS Scores (OR= 40.9, 95%CI= 1.7-48.1, p=0.04) was higher than that during the first wave.

conclusionAcute kidney injury was frequent in hospitalized patients with COVID-19, and the second wave was associated with greater severity. However, mortality rates were similar between the two periods, which may reflect both the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic to provide greater support to their patients. REGISTRY OF CLINICAL TRIALS: RBR-62y3h7.

Indexed as

Acute Kidney InjuryCOVID-19AdultAgedBrazilFemaleHospitalizationHumansIncidenceIntensive Care UnitsMaleMiddle AgedPandemicsProspective StudiesRespiration, ArtificialRisk Factors

Identifiers

PMID39356942
PMCPMC11461013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.